172 related articles for article (PubMed ID: 34595239)
1. UGT1A Gene Family Members Serve as Potential Targets and Prognostic Biomarkers for Pancreatic Cancer.
Feng L; Wang Y; Qin J; Fu Y; Guo Z; Zhang J; He G; Jiang Z; Xu X; Zhou C; Gao Y
Biomed Res Int; 2021; 2021():6673125. PubMed ID: 34595239
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of Immunoinhibitors Identifies LGALS9 and TGFBR1 as Potential Prognostic Biomarkers for Pancreatic Cancer.
Fan Y; Li T; Xu L; Kuang T
Comput Math Methods Med; 2020; 2020():6138039. PubMed ID: 33062039
[TBL] [Abstract][Full Text] [Related]
3. PD-L1 correlated gene expression profiles and tumor infiltrating lymphocytes in pancreatic cancer.
Li J; Yin L; Chen Y; An S; Xiong Y; Huang G; Liu J
Int J Med Sci; 2021; 18(14):3150-3157. PubMed ID: 34400885
[No Abstract] [Full Text] [Related]
4. Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium.
Strassburg CP; Nguyen N; Manns MP; Tukey RH
Mol Pharmacol; 1998 Oct; 54(4):647-54. PubMed ID: 9765507
[TBL] [Abstract][Full Text] [Related]
5. Quantification of Hepatic UDP glucuronosyltransferase 1A splice variant expression and correlation of UDP glucuronosyltransferase 1A1 variant expression with glucuronidation activity.
Jones NR; Sun D; Freeman WM; Lazarus P
J Pharmacol Exp Ther; 2012 Sep; 342(3):720-9. PubMed ID: 22661630
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the prognostic and oncologic values of ITGB superfamily members in pancreatic cancer.
Zhuang H; Zhou Z; Ma Z; Li Z; Liu C; Huang S; Zhang C; Hou B
J Cell Mol Med; 2020 Nov; 24(22):13481-13493. PubMed ID: 33073486
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
8. Regulation of UDP-glucuronosyltransferase 1A1 expression and activity by microRNA 491-3p.
Dluzen DF; Sun D; Salzberg AC; Jones N; Bushey RT; Robertson GP; Lazarus P
J Pharmacol Exp Ther; 2014 Mar; 348(3):465-77. PubMed ID: 24399855
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatic Analysis of Prognostic and Immune-Related Genes in Pancreatic Cancer.
Li Z; Hu C; Yang Z; Yang M; Fang J; Zhou X
Comput Math Methods Med; 2021; 2021():5549298. PubMed ID: 34394706
[TBL] [Abstract][Full Text] [Related]
10. DUOX2 As a Potential Prognostic Marker which Promotes Cell Motility and Proliferation in Pancreatic Cancer.
Cao M; Zhang PB; Wu PF; Chen Q; Ge WL; Shi GD; Yin J; Cai BB; Cao SJ; Miao Y; Jiang KR
Biomed Res Int; 2021; 2021():6530298. PubMed ID: 33748270
[TBL] [Abstract][Full Text] [Related]
11. Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer.
Sun L; Guo C; Cao J; Burnett J; Yang Z; Ran Y; Sun D
Int J Med Sci; 2017; 14(7):655-661. PubMed ID: 28824297
[No Abstract] [Full Text] [Related]
12. Integrated Analysis of Multi-Omics Data to Identify Prognostic Genes for Pancreatic Cancer.
Jiang F; Huang X; Zhang F; Pan J; Wang J; Hu L; Chen J; Wang Y
DNA Cell Biol; 2022 Mar; 41(3):305-318. PubMed ID: 35104421
[TBL] [Abstract][Full Text] [Related]
13. ITGA5 is a prognostic biomarker and correlated with immune infiltration in gastrointestinal tumors.
Zhu H; Wang G; Zhu H; Xu A
BMC Cancer; 2021 Mar; 21(1):269. PubMed ID: 33711961
[TBL] [Abstract][Full Text] [Related]
14. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.
Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B
J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227
[TBL] [Abstract][Full Text] [Related]
15. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer.
Liang Z; Li X
Autoimmunity; 2021 Mar; 54(2):76-87. PubMed ID: 33596760
[TBL] [Abstract][Full Text] [Related]
16. Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis.
Zhang J; Huang S; Quan L; Meng Q; Wang H; Wang J; Chen J
Biomed Res Int; 2021; 2021():8883800. PubMed ID: 33829065
[TBL] [Abstract][Full Text] [Related]
17. PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer.
Li G; Wang X; Liu G
Biomed Res Int; 2021; 2021():5512340. PubMed ID: 34258263
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract][Full Text] [Related]
19. Cross-Talk between Alternatively Spliced UGT1A Isoforms and Colon Cancer Cell Metabolism.
Audet-Delage Y; Rouleau M; Rouleau M; Roberge J; Miard S; Picard F; Têtu B; Guillemette C
Mol Pharmacol; 2017 Mar; 91(3):167-177. PubMed ID: 28049773
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of clinical prognosis and molecular immune characterization of tropomyosin 4 in pancreatic cancer.
Zhou X; Zhu X; Yao J; Wang X; Wang N
Invest New Drugs; 2021 Dec; 39(6):1469-1483. PubMed ID: 33983530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
